Natural killer cell activation after interferon administration in patients with metastatic renal cell carcinoma: An ultrastructural and immunohistochemical study

被引:0
作者
Toliou, T
Stravoravdi, P
Polyzonis, M
Vakalikos, J
机构
[1] THEAGENIO CANC HOSP,GR-54007 THESSALONIKI,GREECE
[2] ARISTOTELIAN UNIV THESSALONIKI,SCH MED,GR-54006 THESSALONIKI,GREECE
关键词
natural killer cells; renal cell carcinoma; interferon; immunohistochemistry; ultrastructure;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: We studied the intralesional number of natural killer (NK) cells and the ultrastructural evidence of their activation in patients with metastatic renal cell carcinoma, after preoperative interferon (IFN) administration. Methods: Tumor sections from 10 patients with metastatic renal cell carcinoma who received preoperative IFN (5 MU x 3 days) and from 10 patients with renal cell carcinoma were obtained. The number of NK cells was estimated immunohistochemically in paraffin sections with the CD57 monoclonal antibody and their activation was evaluated ultrastructurally by routine electron microscopy processing. Results: The number of NK cells was increased in the tumors of the IFN-administered patients (5.3 cells vs. 1.6 in the controls, p = 0.03) while their ultrastructural features revealed activation and enhanced cytolytic activity, through facilitation of granule content release. Conclusions: IFN promotes the aggregation and activation of NK cells within the renal cell tumor, further strengthening the concept of its immunomodulatory acitivity.
引用
收藏
页码:252 / 256
页数:5
相关论文
共 15 条
[1]   EXPANSION OF PERIPHERAL-BLOOD NATURAL-KILLER-CELLS CORRELATES WITH CLINICAL OUTCOME IN CANCER-PATIENTS RECEIVING RECOMBINANT SUBCUTANEOUS INTERLEUKIN-2 AND INTERFERON-ALPHA(2) [J].
ATZPODIEN, J ;
KIRCHNER, H ;
KORFER, A ;
HADAM, M ;
SCHOMBURG, A ;
MENZEL, T ;
DECKERT, M ;
FRANZKE, A ;
VOLKENANDT, M ;
DALLMANN, I ;
GROSSE, J ;
POLIWODA, H .
TUMOR BIOLOGY, 1993, 14 (06) :354-359
[2]  
BERGMANN L, 1993, CANCER-AM CANCER SOC, V72, P1733, DOI 10.1002/1097-0142(19930901)72:5<1733::AID-CNCR2820720537>3.0.CO
[3]  
2-X
[4]   COMBINATION OF INTERLEUKIN-2 AND GAMMA-INTERFERON IN METASTATIC RENAL-CELL CARCINOMA [J].
ESCUDIER, B ;
FARACE, F ;
ANGEVIN, E ;
TRIEBEL, F ;
ANTOUN, S ;
LECLERCQ, B ;
BRANDELY, M ;
ABOUDARAM, A ;
NITENBERG, G ;
HERCEND, T .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (05) :724-728
[5]  
GRUPS JW, 1989, J BIOL REG HOMEOS AG, V3, P98
[6]   CYTOLYTIC ACTIVITY OF PURIFIED CYTOPLASMIC GRANULES FROM CYTO-TOXIC RAT LARGE GRANULAR LYMPHOCYTE TUMORS [J].
HENKART, PA ;
MILLARD, PJ ;
REYNOLDS, CW ;
HENKART, MP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (01) :75-93
[7]  
Kawata N, 1993, Hinyokika Kiyo, V39, P511
[8]  
Maxwell W, 1993, Eur J Surg Oncol, V19, P265
[9]  
POLYZONIS M, 1994, RECENT ADV CHEMOTHER, P819
[10]  
ROBERTSON MJ, 1990, BLOOD, V76, P2421